Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Improve Your Cell-Based Research with Real-Time Assays

 

Summary

In vitro cell-based assays are useful tools for measuring the health of a cell population. These assays can help uncover parameters such as cell viability, death, mitochondrial events, oxidative stress, metabolism and more. While cell-based assays have become an important component of a researcher’s toolkit, traditional endpoint assays can present various challenges. Namely, you can miss important cellular events if the measurement is not taken at the appropriate time, particularly if you are characterizing an unknown compound’s effect on the cells. Furthermore, certain assay reagents can negatively affect the cell sample, so it is imperative to understand the consequences of your chosen assay reagent. Typical endpoint assays are also limiting, as they impede downstream multiplexing.

"Real-time" cell-based assays can resolve these dilemmas. Unlike endpoint assays, real-time assays enable the repeated recording of kinetic data over time without harming the cell sample, and they provide the flexibility of downstream multiplexing. In this webinar, we explore assay design and considerations for plate-based real-time assays, multiplexing and 3D culture. You will gain a better understanding of real-time assays and how to get the most from your cell samples.


Speaker

terry-riss-125x125

Terry Riss, PhD
Global Strategic Marketing Manager, Cell Health

Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and held several R&D and Project Management positions since. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death.  Dr. Riss now serves as Global Strategic Marketing Manager, Cell Health involved in outreach educational training activities.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up